The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Status:
Not yet recruiting
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised
controlled trial in people with chronic kidney disease (CKD).
CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the
progression of CKD so that fewer people develop kidney failure.
CAPTIVATE provides a research platform that allows many treatment-related questions to be
answered within a common trial set-up.